• Insilico Medicine Cayman TopCo to be added to the MSCI Global Small Cap Indexes, effective at the close of Aug. 31, 2026.
• Board views inclusion as a sign of stronger market endorsement of its competitive position, scalable model, and commercial potential.
• Move expected to lift visibility with global institutions, draw passive inflows, broaden ownership, and support share liquidity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12285897), on August 17, 2026, and is solely responsible for the information contained therein.